SCINTIMUN 1 mg trousse per préparation radiopharmaceutique 2 bottles
Active ingredients: Besilesomab
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Radiopharmaceutical preparation kit2 bottlesintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SCINTIMUN 1 mg trousse pour préparation radiopharmaceutique
- Pharmaceutical form
- trousse et trousse pour préparation radiopharmaceutique
- Route of administration
- intraveineuse
- Presentation description
- 2 flacon(s) en verre - 2 flacon(s) en verre
- Marketing authorisation holder
- TELIX INNOVATIONS (BELGIQUE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Jun 2010
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68516450CIP75769142CIP133400957691424Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BESILÉSOMABpoudre | 1 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.